Leap Therapeutics, Inc.
LPTX
$0.3634
-$0.0056-1.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.81% | 9.70% | -45.64% | -10.87% | 8.99% |
| Total Depreciation and Amortization | -- | 100.00% | -195.24% | 2,525.00% | 33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.75% | -7.28% | 23.89% | 201.67% | -78.01% |
| Change in Net Operating Assets | -256.58% | -77.48% | 262.84% | -284.42% | 27.85% |
| Cash from Operations | 0.56% | -14.11% | 11.89% | -49.48% | 1.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 137,827.59% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 97.71% | -- | -- | -- |
| Cash from Financing | 257.58% | -100.18% | 127,889.66% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -1,760.00% | -91.07% | 147.66% | -183.93% | 253.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.52% | -166.46% | 249.84% | -55.66% | 5.36% |